Risedronic Acid-d4
Product Specifications
UNSPSC Description
Risedronic Acid-d4 is the deuterium labeled Risedronic acid. Risedronic acid (Risedronate) is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption[1][2].
Target Antigen
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Solubility
10 mM in DMSO
Smiles
C(CC=1C(=C(C(=NC1[2H])[2H])[2H])[2H])(P(=O)(O)O)(P(=O)(O)O)O
Molecular Weight
287.14
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Giljevic Z, et al. Treatment of osteoporosis by risedronate-- speed, efficacy and safety. Reumatizam. 2006;53(2):66-71.|[3]Jordao FM, et al. In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum. Antimicrob Agents Chemother. 2011 May;55(5):2026-31.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
CAS Number
1035438-80-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1346309-01 0.02 mg (E-Coli)
Recombinant Human herpesvirus 1 Virion host shutoff protein (UL41)
Ask
View Details MBS1346309-02 0.02 mg (Yeast)
Recombinant Human herpesvirus 1 Virion host shutoff protein (UL41)
Ask
View Details MBS1346309-03 0.1 mg (E-Coli)
Recombinant Human herpesvirus 1 Virion host shutoff protein (UL41)
Ask
View Details